Browsing Tag
OneSource Specialty Pharma Limited
2 posts
Brazil opens doors to OneSource’s GLP-1 drugs as Bengaluru plant gets ANVISA nod
OneSource earns ANVISA GMP nod for Bengaluru plant, unlocking Brazil’s fast-growing market for GLP-1 biologics. Find out how it boosts global CDMO reach.
April 13, 2025
OneSource secures $95m from leading investors; Strides Pharma shareholders witness surge in embedded value
OneSource Specialty Pharma Limited, previously known as Stelis Biopharma, has received equity commitments amounting to INR 8,010 million…
October 16, 2024